A University of Basel spin-off, NanoZymeX is developing a lipid nanoparticle platform to improve enzyme replacement therapies. The startup has secured CHF 150,000 from Venture Kick for preclinical studies and to prepare for scaled-up production.
- Announced on
- Round
- Grant
- Amount
- CHF 150,000
- Location
- canton of Basel-Stadt
- Sector
- Biotech & life sciences
Investors
- Venture Kick lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic